Skip to main content
Journal cover image

Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.

Publication ,  Journal Article
Marsh, K; van Til, JA; Molsen-David, E; Juhnke, C; Hawken, N; Oehrlein, EM; Choi, YC; Duenas, A; Greiner, W; Haas, K; Hiligsmann, M; Ivlev, I ...
Published in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
July 2020

This study examines European decision makers' consideration and use of quantitative preference data.The study reviewed quantitative preference data usage in 31 European countries to support marketing authorization, reimbursement, or pricing decisions. Use was defined as: agency guidance on preference data use, sponsor submission of preference data, or decision-maker collection of preference data. The data could be collected from any stakeholder using any method that generated quantitative estimates of preferences. Data were collected through: (1) documentary evidence identified through a literature and regulatory websites review, and via key opinion leader outreach; and (2) a survey of staff working for agencies that support or make healthcare technology decisions.Preference data utilization was identified in 22 countries and at a European level. The most prevalent use (19 countries) was citizen preferences, collected using time-trade off or standard gamble methods to inform health state utility estimation. Preference data was also used to: (1) value other impact on patients, (2) incorporate non-health factors into reimbursement decisions, and (3) estimate opportunity cost. Pilot projects were identified (6 countries and at a European level), with a focus on multi-criteria decision analysis methods and choice-based methods to elicit patient preferences.While quantitative preference data support reimbursement and pricing decisions in most European countries, there was no utilization evidence in European-level marketing authorization decisions. While there are commonalities, a diversity of usage was identified between jurisdictions. Pilots suggest the potential for greater use of preference data, and for alignment between decision makers.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

DOI

EISSN

1524-4733

ISSN

1098-3015

Publication Date

July 2020

Volume

23

Issue

7

Start / End Page

831 / 841

Related Subject Headings

  • Technology Assessment, Biomedical
  • Surveys and Questionnaires
  • Research Design
  • Reimbursement Mechanisms
  • Pilot Projects
  • Patient Preference
  • Humans
  • Health Services Research
  • Health Policy & Services
  • Europe
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marsh, K., van Til, J. A., Molsen-David, E., Juhnke, C., Hawken, N., Oehrlein, E. M., … Muehlbacher, A. (2020). Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 23(7), 831–841. https://doi.org/10.1016/j.jval.2019.11.009
Marsh, Kevin, Janine A. van Til, Elizabeth Molsen-David, Christine Juhnke, Natalia Hawken, Elisabeth M. Oehrlein, Y Christy Choi, et al. “Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 23, no. 7 (July 2020): 831–41. https://doi.org/10.1016/j.jval.2019.11.009.
Marsh K, van Til JA, Molsen-David E, Juhnke C, Hawken N, Oehrlein EM, et al. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Jul;23(7):831–41.
Marsh, Kevin, et al. “Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 23, no. 7, July 2020, pp. 831–41. Epmc, doi:10.1016/j.jval.2019.11.009.
Marsh K, van Til JA, Molsen-David E, Juhnke C, Hawken N, Oehrlein EM, Choi YC, Duenas A, Greiner W, Haas K, Hiligsmann M, Hockley KS, Ivlev I, Liu F, Ostermann J, Poder T, Poon JL, Muehlbacher A. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2020 Jul;23(7):831–841.
Journal cover image

Published In

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

DOI

EISSN

1524-4733

ISSN

1098-3015

Publication Date

July 2020

Volume

23

Issue

7

Start / End Page

831 / 841

Related Subject Headings

  • Technology Assessment, Biomedical
  • Surveys and Questionnaires
  • Research Design
  • Reimbursement Mechanisms
  • Pilot Projects
  • Patient Preference
  • Humans
  • Health Services Research
  • Health Policy & Services
  • Europe